163 related articles for article (PubMed ID: 9873466)
21. Induction of apoptosis by cryptophycin 1, a new antimicrotubule agent.
Mooberry SL; Busquets L; Tien G
Int J Cancer; 1997 Nov; 73(3):440-8. PubMed ID: 9359493
[TBL] [Abstract][Full Text] [Related]
22. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
[TBL] [Abstract][Full Text] [Related]
23. Total synthesis of [(2S)-Hiv2]didemnin M.
Liang B; Vera MD; Joullié MM
J Org Chem; 2000 Jul; 65(15):4762-5. PubMed ID: 10959892
[No Abstract] [Full Text] [Related]
24. Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460 NSCLC cells.
Lu K; Dempsey J; Schultz RM; Shih C; Teicher BA
Cancer Chemother Pharmacol; 2001; 47(2):170-8. PubMed ID: 11269744
[TBL] [Abstract][Full Text] [Related]
25. Stereospecific synthesis of cryptophycin 1.
Li LH; Tius MA
Org Lett; 2002 May; 4(10):1637-40. PubMed ID: 12000261
[TBL] [Abstract][Full Text] [Related]
26. Interactions of antimitotic peptides and depsipeptides with tubulin.
Hamel E
Biopolymers; 2002; 66(3):142-60. PubMed ID: 12385035
[TBL] [Abstract][Full Text] [Related]
27. Total syntheses and biological investigations of tamandarins A and B and tamandarin A analogs.
Liang B; Richard DJ; Portonovo PS; Joullié MM
J Am Chem Soc; 2001 May; 123(19):4469-74. PubMed ID: 11457232
[TBL] [Abstract][Full Text] [Related]
28. Cryptophycin anticancer drugs revisited.
Rohr J
ACS Chem Biol; 2006 Dec; 1(12):747-50. PubMed ID: 17240971
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of didemnin photoaffinity analogues.
Vera MD; Pfizenmayer AJ; Ding X; Ahuja D; Toogood PL; Joullié MM
Bioorg Med Chem Lett; 2001 Jul; 11(14):1871-4. PubMed ID: 11459650
[TBL] [Abstract][Full Text] [Related]
30. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1.
Bai R; Durso NA; Sackett DL; Hamel E
Biochemistry; 1999 Oct; 38(43):14302-10. PubMed ID: 10572005
[TBL] [Abstract][Full Text] [Related]
31. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC
Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816
[TBL] [Abstract][Full Text] [Related]
32. Total synthesis of cryptophycin analogues via a scaffold approach.
McCubbin JA; Maddess ML; Lautens M
Org Lett; 2006 Jul; 8(14):2993-6. PubMed ID: 16805535
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and cytostatic activities of didemnin derivatives.
Schmidt U; Griesser H; Haas G; Kroner M; Riedl B; Schumacher A; Sutoris F; Haupt A; Emling F
J Pept Res; 1999 Aug; 54(2):146-61. PubMed ID: 10461749
[TBL] [Abstract][Full Text] [Related]
34. Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin.
Cruz-Monserrate Z; Vervoort HC; Bai R; Newman DJ; Howell SB; Los G; Mullaney JT; Williams MD; Pettit GR; Fenical W; Hamel E
Mol Pharmacol; 2003 Jun; 63(6):1273-80. PubMed ID: 12761336
[TBL] [Abstract][Full Text] [Related]
35. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
[TBL] [Abstract][Full Text] [Related]
36. Cryptophycin 1 cellular levels and effects in vitro using L1210 cells.
Foster BJ; Fortuna M; Media J; Wiegand RA; Valeriote FA
Invest New Drugs; 1998-1999; 16(3):199-204. PubMed ID: 10360599
[TBL] [Abstract][Full Text] [Related]
37. Total synthesis of sandramycin and its analogues via a multicomponent assemblage.
Katayama K; Nakagawa K; Takeda H; Matsuda A; Ichikawa S
Org Lett; 2014 Jan; 16(2):428-31. PubMed ID: 24341513
[TBL] [Abstract][Full Text] [Related]
38. A convergent synthesis of (+)-cryptophycin B, a potent antitumor macrolide from Nostoc sp. cyanobacteria.
Ghosh AK; Bischoff A
Org Lett; 2000 Jun; 2(11):1573-5. PubMed ID: 10841482
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological activities of hapalosin derivatives with modification at the C12 position.
Kashihara N; To-e S; Nakamura K; Umezawa K; Yamamura S; Nishiyama S
Bioorg Med Chem Lett; 2000 Jan; 10(2):101-3. PubMed ID: 10673089
[TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis and Biological Evaluation of a Structurally Simplified Syringolin A Analogues.
Chiba T; Kitahata S; Matsuda A; Ichikawa S
Chem Pharm Bull (Tokyo); 2016; 64(7):811-6. PubMed ID: 27373636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
